How successful is a country-wide selection algorithm for patients receiving CAR T therapy?

The Lymphoma Hub are pleased to present a series of expert interviews from the 2nd European CAR T Cell Meeting in Sitges, ES. In this video, Ulrich Jäger, Medical University of Vienna, Vienna, AT, discusses whether a country-wide selection algorithm for patients receiving CAR T therapy is successful.

Ulrich Jäger discusses the development of an Austrian network that aims to ensure that all patients have fair access to CAR T cell treatments. This network will review the patient data generated by their registry, biobank, clinical study network and prospectively monitor what they have achieved.

#CART,#CART20,#CARTmeeting20,#UlrichJager,#lymphoma hub,